在下第三手术中,克洛尼丁与上腺素的血液动力稳定性与上腺素相比
Jyoti Bhavani Penumarti1, Vinay Kharsan1, Abhishek Balani1
1Department of Oral and Maxillofacial Surgery, New Horizon Dental College and Research Institute, Bilaspur, Chhattisgarh, India.
Bioinformation
|August 18, 2025
概括
与上腺素相比,克洛尼丁与林格诺卡因结合在受冲击的下第三手术期间提供了优越的血液动力控制. 这使得克洛尼丁对于需要稳定的心血管功能的患者来说是一个更安全的麻醉选择.
科学领域:
- 牙科 牙科是指牙科的专业.
- 麻醉学 麻醉学
- 药理学 药理学是指药理学的学科.
背景情况:
- 被冲击的下第三手术通常需要用血管缩剂进行局部麻醉.
- 上腺素是常用的,但可以引起显著的血液动力学波动.
- 寻求替代麻醉剂来提高患者的安全性和心血管稳定性.
研究的目的:
- 为了比较2%的林戈卡因与克洛尼丁的疗效和安全性,而不是2%的林戈卡因与上腺素,用于受冲击的下第三手术.
- 为了评估血液动力学稳定性,麻醉开始和两种麻醉组合之间的持续时间.
- 为了确定克洛尼丁是否为心血管问题患者提供更安全的替代品.
主要方法:
- 一项随机临床试验,涉及70名年龄在18-40岁的患者,接受了受冲击的下第三手术.
- 患者被随机分配,接受2%的林戈卡因与克洛尼丁或2%的林戈卡因与上腺素.
- 血液动力学参数 (压缩性血压,压缩性血压,心率,平均动脉压),麻醉的开始和持续时间被评估.
主要成果:
- 林可卡因-克洛尼丁组表现出明显较低的手术前和手术后静脉血压,透气血压,心率和平均动脉压.
- 虽然克洛尼丁的麻醉开始稍慢,但整体血液动力学控制优越.
- 没有明确详细说明麻醉持续时间的显著差异,但血液动力学稳定性是主要结果.
结论:
- 2%的林戈卡因与克洛尼丁一起在受冲击的下第三手术期间提供了优越的血液动力稳定性,而2%的林戈卡因与上腺素相比.
- 克隆丁是一种潜在的更安全的麻醉替代品,用于在牙科手术期间需要心血管稳定性的患者.
- 进一步的研究可以探索克洛尼丁在牙科麻醉中的长期影响和最佳剂量.
相关概念视频
Adrenergic Agonists: Therapeutic Uses
947
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
947
Cardiopulmonary Resuscitation IV: Pharmacological Management
75
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
75
Adrenergic Antagonists: ɑ and β-Receptor Blockers
598
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
598
Cardiomyopathy VII: Pre and Post Operative Nursing Management
27
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
27
Depolarizing Blockers: Pharmocokinetics
379
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
379
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
847
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
847


